1Yu WL,Chuang YC,Jones RN.A pragmatic approach to identify extended-spectrum beta-lactamase-producing klebsiella pneumoniae in Taiwan:in vitro activity of newer and established antimicrobial agents.Diagn Microbiol Infect Dis,2004,48(4):277-282
2Gupta A,Della-Latta P,Todd B,et al.Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails.Infect Control Hosp Epidemiol,2004,25(3):210-215
3Sturenburg E,Mack D.Extended-spectrum beta-lactamases:implications for the clinical microbiology laboratory,therapy,and infection control.J Infect,2003,47(4):273-295
4Lavigne JP,Bonnet R,Michaux-Charachon S,et al.Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.J Antimicrob Chemother,2004,53(4):616-619
5Pfaller MA,Jones RN.Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme,Europe 1997-2000.Int J Antimicrob Agents,2002,19(5):383-
1Barnaud G, Labia R, Raskine L, et al. Extension of resistance to cefepime and eefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett, 2001,195: 185-190.
2Bush K, Jaeoby GA, Medeiros AA. A functional elassification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995, 39: 12111233.
3Stapleton P, Shannon K, Phillips I. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob Agents Chemother, 1995, 39:2494-2498.
4Normark S. Beta-lactamase induction in gram negative bacteria is intimately linked to peptidoglycan recycling. Microb Drug Resist, 1995, 1:111-114.
5Bauernfeind A, Wagner S, Jungwirth R, et al. A novel class C beta lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother, 1997, 41:2041-2046.
6Campbell JI, Ciofu O, Hoiby N. Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region. Antimicrob Agents Chemother, 1997, 41: 1380-1384.
7Chan WC, Li RC, Ling JM, et al. Markedly different rates and resistance profiles exhibited by sever commonly used and newer β beta-lactams on the selection of resistant variants of Enterobacter cloacae. J Antimicrob Chemother, 1999, 43: 55-60.